Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Emerging treatment strategies and potential therapeutic targets in primary Sjögren's syndrome.

Becker H, Pavenstaedt H, Willeke P.

Inflamm Allergy Drug Targets. 2010 Mar;9(1):10-9. Review.

PMID:
19906008
2.

[Indications and options of new immune modulatory therapies for Sjögren's syndrome].

Feist E, Dörner T, Hansen A.

Z Rheumatol. 2007 Dec;66(8):679-85. Review. German.

PMID:
17999070
3.

The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome.

Baldini C, Rossi C, Ferro F, Santini E, Seccia V, Donati V, Solini A.

J Intern Med. 2013 Nov;274(5):480-9. doi: 10.1111/joim.12115. Epub 2013 Aug 17.

4.

[Current therapeutic options in Sjögren's syndrome].

Hansen A, Dörner T.

Z Rheumatol. 2010 Feb;69(1):19-24. doi: 10.1007/s00393-009-0515-6. Review. German.

PMID:
20013285
5.

Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy.

Hansen A, Lipsky PE, Dörner T.

Curr Opin Rheumatol. 2005 Sep;17(5):558-65. Review.

PMID:
16093833
7.

Treatment of primary Sjögren's syndrome with hydroxychloroquine.

Fox RI, Chan E, Benton L, Fong S, Friedlaender M, Howell FV.

Am J Med. 1988 Oct 14;85(4A):62-7.

PMID:
3177432
8.

Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren's syndrome.

Jonsson R, Gordon TP, Konttinen YT.

Curr Rheumatol Rep. 2003 Aug;5(4):311-6. Review.

PMID:
14531959
9.

Primary Sjogren's syndrome: current and prospective therapies.

Thanou-Stavraki A, James JA.

Semin Arthritis Rheum. 2008 Apr;37(5):273-92. Epub 2007 Aug 21. Review.

PMID:
17714766
10.

Biologic treatments in Sjögren's syndrome.

Bowman S, Barone F.

Presse Med. 2012 Sep;41(9 Pt 2):e495-509. doi: 10.1016/j.lpm.2012.05.024. Epub 2012 Jul 24. Review.

PMID:
22836195
11.

The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome.

Saraux A.

Autoimmun Rev. 2010 Jul;9(9):609-14. doi: 10.1016/j.autrev.2010.05.007. Epub 2010 May 7. Review.

PMID:
20452466
12.

Sjögren's syndrome--a plethora of clinical and immunological phenotypes with a complex genetic background.

Jonsson R, Bolstad AI, Brokstad KA, Brun JG.

Ann N Y Acad Sci. 2007 Jun;1108:433-47. Review.

PMID:
17894008
13.

Biologic therapies in primary Sjögren's syndrome.

Bowman SJ.

Curr Pharm Biotechnol. 2012 Aug;13(10):1997-2008. Review.

PMID:
22208654
14.

Emerging biological therapies in primary Sjogren's syndrome.

Ramos-Casals M, Brito-Zerón P.

Rheumatology (Oxford). 2007 Sep;46(9):1389-96. Epub 2007 Jun 22. Review.

15.

Anti-CD20 treatment in primary Sjögren's syndrome.

Isaksen K, Jonsson R, Omdal R.

Scand J Immunol. 2008 Dec;68(6):554-64. doi: 10.1111/j.1365-3083.2008.02185.x. Epub 2008 Oct 23. Review.

16.

Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.

Moutsopoulos NM, Katsifis GE, Angelov N, Leakan RA, Sankar V, Pillemer S, Wahl SM.

Ann Rheum Dis. 2008 Oct;67(10):1437-43. doi: 10.1136/ard.2007.077891. Epub 2008 Jan 15.

PMID:
18198195
17.

Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.

Willeke P, Gaubitz M, Schotte H, Maaser C, Domschke W, Schlüter B, Becker H.

Arthritis Res Ther. 2007;9(2):R43.

18.

Anti-CD20 antibody in primary Sjögren's syndrome management.

Chen S, Liu Y, Shi G.

Curr Pharm Biotechnol. 2014;15(6):535-41. Review.

PMID:
25213362
19.

B-cell hyperactivity in primary Sjögren's syndrome.

Kroese FG, Abdulahad WH, Haacke E, Bos NA, Vissink A, Bootsma H.

Expert Rev Clin Immunol. 2014 Apr;10(4):483-99. doi: 10.1586/1744666X.2014.891439. Epub 2014 Feb 25. Review.

PMID:
24564507
20.

An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome.

Mackay F, Groom JR, Tangye SG.

Curr Opin Rheumatol. 2007 Sep;19(5):406-13. Review.

PMID:
17762603
Items per page

Supplemental Content

Write to the Help Desk